Foundation Medicine Inc Stock

Stocks

21/10/18	Bayer : Roche takes on Loxo, Bayer in gene-defined cancer class	RE
19/06/18	Citigroup : Roche pays $2.4 billion for rest of cancer expert Foundation Medicine	RE
04/12/17	Foundation Medicine : Roche's Foundation Medicine wins FDA blessing for new cancer test	RE
13/01/15	Alcoa : Wall St. falls; energy shares dragged down further by oil	RE
12/01/15	Foundation Medicine : Roche in $1 billion-plus Foundation Medicine deal to boost cancer efforts	RE

07/08/18	Foundation Medicine : Setting the Pace for Blood Tumor Mutational Burden	PU
06/08/18	Foundation Medicine : Publishes New Data in Nature Medicine Supporting Blood Tumor Mutational Burden (bTMB) as a Novel Predictor of Response to Cancer Immunotherapy	BU
18/07/18	Foundation Medicine : and Guardant Health Agree to Settle Patent Infringement Lawsuit	BU
03/07/18	Beyond MSI: Expanding the Reach of Immunotherapy in Colorectal Cancer	PU
20/06/18	FOUNDATION MEDICINE, INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout	BU

19/06/18	Les valeurs à suivre aujourd'hui à Wall Street Mardi 19 juin 2018
19/06/18	Dow Jones Industrial Average : Les valeurs à suivre à Wall Street
19/06/18	FOUNDATION MEDICINE : racheté par ROCHE
19/06/18	USA-Les valeurs à suivre à Wall Street (actualisé)
19/06/18	Foundation Medicine : Roche will US-Gentest-Firma FMI ganz schlucken

Manager	Title	Age	Since
Daniel Malarek CEO	Chief Executive Officer	-	01/11/2023
Dominique Schutz DFI	Director of Finance/CFO	-	01/01/2022
Michael Kling CTO	Chief Tech/Sci/R&D Officer	-	-

Director	Title	Age	Since
Evan Jones BRD	Director/Board Member	69	08/01/2013

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
FOUNDATION MEDICINE INC	-.--%	-.--%	-	-	0
WUXI APPTEC CO., LTD.	-6.60%	-8.56%	+49.38%	+63.51%	65B
LONZA GROUP AG	+0.03%	+5.56%	+9.10%	+69.05%	51.2B
ARGENX SE	-4.09%	-0.11%	+2.22%	+53.15%	51.19B
IQVIA HOLDINGS INC.	-1.53%	+2.70%	+30.48%	+34.12%	43.93B
BEONE MEDICINES AG	-1.34%	+4.12%	+16.64%	+115.13%	41.96B
REVOLUTION MEDICINES, INC.	-5.97%	-6.22%	+228.95%	+454.22%	38.14B
CELLTRION, INC.	+6.53%	+8.02%	+16.40%	+53.41%	33.24B
WUXI BIOLOGICS (CAYMAN) INC.	-0.90%	-10.49%	+37.09%	-3.70%	25.2B
GENMAB A/S	-1.07%	+2.33%	+19.43%	+9.98%	22.5B
Average	-1.49%	-0.35%	+45.52%	+94.32%	41.37B
Weighted average by Cap.	-2.20%	-0.50%	+44.25%	+96.53%

Employees

Sector